As Progress from Royal Liver reaches its five year milestone, Mike Warr discusses a narrowing of the market's focus with Paul Robertson
When a new company comes to market it tends to be the best of breed, to raise the bar for other firms in the market. Eventually as others adopt the innovations they see as being relevant in their markets the new boy finds itself becoming just another market player. So a firm’s adolescence is a good time to take stock. By lucky coincidence Progress from Royal Liver has just passed its fifth year. The starting point of Progress was Royal Liver looking for new ways to market and search for new propositions. Five years ago Royal Liver was still collecting on the doorstep and still had a dire...
To continue reading this article...
Join Professional Adviser for free
- Unlimited access to real-time news, industry insights and market intelligence
- Stay ahead of the curve with spotlights on emerging trends and technologies
- Receive breaking news stories straight to your inbox in the daily newsletters
- Make smart business decisions with the latest developments in regulation, investing retirement and protection
- Members-only access to the editor’s weekly Friday commentary
- Be the first to hear about our events and awards programmes